ZHONGHENG GROUP(SH:600252) Zheng Quan Zhi Xing·2025-08-21 11:18Summary of Key Points Core Viewpoint - The announcement details the provision of a guarantee by Guangxi Wuzhou Zhongheng Group Co., Ltd. for its wholly-owned subsidiary, Chongqing Laimeilongyu Pharmaceutical Co., Ltd., to secure a financing credit line of RMB 10 million from Hengfeng Bank, with a total guarantee amount of RMB 39.4 million [1][4]. Group 1: Guarantee Details - The guarantee amount for Chongqing Laimeilongyu is RMB 10 million, with an actual guarantee balance of RMB 39.4 million [1]. - The total external guarantee amount by the company and its subsidiaries is RMB 373.49 million, which represents 6.20% of the company's latest audited net assets [1][4]. - There are no overdue guarantees as of the date of the announcement [1][4]. Group 2: Internal Decision-Making Process - The company held board meetings on March 27, 2025, and April 28, 2025, to approve the guarantee proposal, which falls within the previously approved comprehensive credit limit of RMB 5 billion for 2025 [2]. - The total guarantee limit approved is up to RMB 2.5 billion, and this specific guarantee does not require further board or shareholder approval [2]. Group 3: Financial Overview of the Guaranteed Entity - Chongqing Laimeilongyu Pharmaceutical Co., Ltd. has total assets of RMB 535.71 million and total liabilities of RMB 304.30 million as of June 2025 [3]. - The company reported a net asset of RMB 231.41 million and an operating income of RMB 46.63 million for the first half of 2025 [3]. Group 4: Necessity and Reasonableness of the Guarantee - The guarantee is deemed necessary and reasonable as it aligns with the operational needs of Laimeilongyu and is within the legal and regulatory framework [3]. - The company’s board has confirmed that the risks associated with the guarantee are manageable and that it supports the long-term business development of the subsidiary [3].